• / Free eNewsletters & Magazine
  • / My Account
Home>European Commission

European Commission

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Apple Goes Without a Lobby Into European Fray

    Apple Goes Without a Lobby Into European Fray

  2. Apple to Battle EU Regulator Without Usual Lobbying Army

    Apple to Battle EU Regulator Without Usual Lobbying Army

  3. eu-LISA Selects Accenture, Atos and Safran to Enhance EU Visa Information and Biometric Matching System

    eu-LISA Selects Accenture, Atos and Safran to Enhance EU Visa Information and Biometric Matching System

  4. News Highlights: Top Equities Stories of the Day

    News Highlights: Top Equities Stories of the Day

  5. European Commission Approves Ipsen’s Cabometyx™ (Cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults Following Prior Vascular Endothelial Growth Factor ...

    European Commission Approves Ipsen’s Cabometyx™ (Cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy

  6. European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy

    European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy

  7. Switzerland Moves Closer to Compromise Over EU Immigration

    Switzerland Moves Closer to Compromise Over EU Immigration

  8. France's Sapin Says European Upswing Not Sufficient Amid Potential Risks--Update

    France's Sapin Says European Upswing Not Sufficient Amid Potential Risks--Update

  9. WTO Expected to Rule Against EU on Airbus Subsidies

    WTO Expected to Rule Against EU on Airbus Subsidies

  10. EU Rules Against U.K. Over RWE Coal Plant

    EU Rules Against U.K. Over RWE Coal Plant

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.